{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T05:47:11Z","timestamp":1792129631181,"version":"4.4.0"},"reference-count":115,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organization for Health Research and Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003246","name":"NWO","doi-asserted-by":"publisher","award":["917.17.308"],"award-info":[{"award-number":["917.17.308"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"NWO","doi-asserted-by":"publisher","award":["918.19.627"],"award-info":[{"award-number":["918.19.627"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003180","name":"Academic Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003180","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,1]]},"abstract":"<jats:p>Morbidity and mortality in bacterial meningitis are driven by an uncontrolled host inflammatory response. Koelman et al. evaluate the detrimental role of the complement system in spurring this inflammation, and conclude that anaphylatoxin C5a is a promising treatment target in bacterial meningitis.<\/jats:p>","DOI":"10.1093\/brain\/awz222","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T15:37:23Z","timestamp":1562254643000},"page":"3325-3337","source":"Crossref","is-referenced-by-count":54,"title":["Targeting the complement system in bacterial meningitis"],"prefix":"10.1093","volume":"142","author":[{"given":"Diederik L H","family":"Koelman","sequence":"first","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam, Department of Neurology, Amsterdam Neuroscience, Meibergdreef 9, AZ, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs C","family":"Brouwer","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam, Department of Neurology, Amsterdam Neuroscience, Meibergdreef 9, AZ, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederik","family":"van de Beek","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam, Department of Neurology, Amsterdam Neuroscience, Meibergdreef 9, AZ, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,8,2]]},"reference":[{"key":"2019103013381200400_awz222-B1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jinf.2012.10.008","article-title":"Common polymorphisms in the complement system and susceptiblity to bacterial meningitis","volume":"66","author":"Adriani","year":"2013","journal-title":"J Infect"},{"key":"2019103013381200400_awz222-B2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12916-016-0755-7","article-title":"Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis","volume":"14","author":"Alari","year":"2016","journal-title":"BMC Med"},{"key":"2019103013381200400_awz222-B3","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1073\/pnas.1401011111","article-title":"Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infection","volume":"111","author":"Ali","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019103013381200400_awz222-B4","doi-asserted-by":"crossref","first-page":"e1002793","DOI":"10.1371\/journal.ppat.1002793","article-title":"The lectin pathway of complement activation is a critical component of the innate immune response to pneumococcal infection","volume":"8","author":"Ali","year":"2012","journal-title":"PLoS Pathog"},{"key":"2019103013381200400_awz222-B5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnagi.2018.00021","article-title":"Use of peptides for the management of Alzheimer\u2019s disease: diagnosis and inhibition","volume":"10","author":"Baig","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"2019103013381200400_awz222-B6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000371423","article-title":"C4a: An anaphylatoxin in name only","volume":"7","author":"Barnum","year":"2015","journal-title":"J Innate Immun"},{"key":"2019103013381200400_awz222-B7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1473-3099(15)00430-2","article-title":"Community-acquired bacterial meningitis in adults in the Netherlands, 2006\u201314: a prospective cohort study","volume":"16","author":"Bijlsma","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2019103013381200400_awz222-B8","doi-asserted-by":"crossref","first-page":"e0120757","DOI":"10.1371\/journal.pone.0120757","article-title":"Susceptibility to invasive meningococcal disease: polymorphism of complement system genes and Neisseria meningitidis factor H binding protein","volume":"10","author":"Bradley","year":"2015","journal-title":"PLoS One"},{"key":"2019103013381200400_awz222-B9","doi-asserted-by":"crossref","first-page":"e65151","DOI":"10.1371\/journal.pone.0065151","article-title":"Genetic variation and cerebrospinal fluid levels of mannose binding lectin in pneumococcal meningitis patients","volume":"8","author":"Brouwer","year":"2013","journal-title":"PLoS One"},{"key":"2019103013381200400_awz222-B10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1473-3099(08)70261-5","article-title":"Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis","volume":"9","author":"Brouwer","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"2019103013381200400_awz222-B11","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1212\/WNL.0b013e3181f96297","article-title":"Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis","volume":"75","author":"Brouwer","year":"2010","journal-title":"Neurology"},{"key":"2019103013381200400_awz222-B12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/QCO.0000000000000417","article-title":"Epidemiology of community-acquired bacterial meningitis","volume":"31","author":"Brouwer","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"2019103013381200400_awz222-B13","doi-asserted-by":"crossref","first-page":"16969","DOI":"10.1073\/pnas.012669199","article-title":"The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice","volume":"99","author":"Brown","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019103013381200400_awz222-B14","first-page":"362","article-title":"Therapeutic inhibition of the complement system in diseases of the central nervous system","volume":"10","author":"Carpanini","year":"2019"},{"key":"2019103013381200400_awz222-B15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(01)08319-2","article-title":"Pneumococcal meningitis since the introduction of M. & B. 693","volume":"236","author":"Coleman","year":"1940","journal-title":"Lancet"},{"key":"2019103013381200400_awz222-B16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nrmicro.2016.178","article-title":"A journey into the brain: insight into how bacterial pathogens cross blood-brain barriers","volume":"15","author":"Coureuil","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"2019103013381200400_awz222-B17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/cbdd.12055","article-title":"The future of peptide-based drugs","volume":"81","author":"Craik","year":"2013","journal-title":"Chem Biol Drug Des"},{"key":"2019103013381200400_awz222-B18","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1128\/IAI.14.4.882-887.1976","article-title":"Participation of complement in the nonimmune host defense against experimental Haemophilus influenzae type b septicemia and meningitis","volume":"14","author":"Crosson","year":"1976","journal-title":"Infect Immun"},{"key":"2019103013381200400_awz222-B19","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/brain\/awg141","article-title":"Pneumococcal meningitis: antibiotics essential but insufficient","volume":"126","author":"Davis","year":"2003","journal-title":"Brain"},{"key":"2019103013381200400_awz222-B20","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJMoa021334","article-title":"Dexamethasone in adults with bacterial meningitis","volume":"347","author":"de Gans","year":"2002","journal-title":"New Engl J Med"},{"key":"2019103013381200400_awz222-B21","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(19)30040-4","article-title":"Standing on the shoulders of giants: two centuries of struggle against meningococcal disease","author":"Domingo","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2019103013381200400_awz222-B22","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1378\/chest.08-0642","article-title":"Mannose-binding lectin genotypes in susceptibility to community-acquired pneumonia","volume":"134","author":"Endeman","year":"2008","journal-title":"Chest"},{"key":"2019103013381200400_awz222-B23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40478-016-0297-4","article-title":"Pneumococcal meningitis: clinical-pathological correlations (MeninGene-Path)","volume":"4","author":"Engelen-Lee","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"2019103013381200400_awz222-B24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/IAI.46.1.81-86.1984","article-title":"Complement (C5)-derived chemotactic activity accounts for accumulation of polymorphonuclear leukocytes in cerebrospinal fluid of rabbits with pneumococcal meningitis","volume":"46","author":"Ernst","year":"1984","journal-title":"Infect Immun"},{"key":"2019103013381200400_awz222-B25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.inf.0000256751.76218.7c","article-title":"Age-dependent association of human mannose-binding lectin mutations with susceptibility to invasive meningococcal disease in childhood","volume":"26","author":"Faber","year":"2007","journal-title":"Pediatric Infect Dis J"},{"key":"2019103013381200400_awz222-B26","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1007\/s00134-004-2303-8","article-title":"Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin","volume":"30","author":"Fidler","year":"2004","journal-title":"Intensiv Care Med"},{"key":"2019103013381200400_awz222-B27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1086\/515075","article-title":"Assessment of complement deficiency in patients with meningococcal disease in The Netherlands","volume":"28","author":"Fijen","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2019103013381200400_awz222-B28","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJM193806232182501","article-title":"Treatment of Pneumococcic Meningitis","volume":"218","author":"Finland","year":"1938","journal-title":"New Engl J Med"},{"key":"2019103013381200400_awz222-B29","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0022-3476(35)80229-1","article-title":"Observations on the presence of complement in the cerebrospinal fluid in various pathologic conditions of the central nervous system","volume":"6","author":"Fothergill","year":"1935","journal-title":"J Pediatr"},{"key":"2019103013381200400_awz222-B30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuropharm.2016.03.014","article-title":"Antibody therapies in CNS diseases","volume":"120","author":"Freskg\u00e5rd","year":"2017","journal-title":"Neuropharmacology"},{"key":"2019103013381200400_awz222-B31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1183\/09031936.00174111","article-title":"The role of mannose-binding lectin in pneumococcal infection","volume":"41","author":"Garc\u00eda-Laorden","year":"2013","journal-title":"Eur Respir J"},{"key":"2019103013381200400_awz222-B32","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jaci.2008.05.037","article-title":"Mannose-binding lectin and mannose-binding lectin-associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adults","volume":"122","author":"Garcia-Laorden","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"2019103013381200400_awz222-B33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.diagmicrobio.2012.02.002","article-title":"Genetic variants of the MBL2 gene are associated with mortality in pneumococcal sepsis","volume":"73","author":"Garnacho-Montero","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2019103013381200400_awz222-B34","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1086\/379044","article-title":"Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome","volume":"188","author":"Garred","year":"2003","journal-title":"J Infect Dis"},{"key":"2019103013381200400_awz222-B35","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.4049\/jimmunol.160.7.3543","article-title":"The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis","volume":"160","author":"Gasque","year":"1998","journal-title":"J Immunol"},{"key":"2019103013381200400_awz222-B36","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.vaccine.2015.03.012","article-title":"Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction","volume":"33","author":"Gladstone","year":"2015","journal-title":"Vaccine"},{"key":"2019103013381200400_awz222-B37","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1086\/654819","article-title":"Proteomic analysis of cerebrospinal fluid in pneumococcal meningitis reveals potential biomarkers associated with survival","volume":"202","author":"Goonetilleke","year":"2010","journal-title":"J Infect Dis"},{"key":"2019103013381200400_awz222-B38","doi-asserted-by":"crossref","first-page":"e00272","DOI":"10.1128\/mBio.00272-11","article-title":"Death is associated with complement C3 depletion in cerebrospinal fluid of patients with pneumococcal meningitis","volume":"3","author":"Goonetilleke","year":"2012","journal-title":"MBio"},{"key":"2019103013381200400_awz222-B39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12987-017-0079-9","article-title":"Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017","volume":"14","author":"Greenwood","year":"2017","journal-title":"Fluids Barriers CNS"},{"key":"2019103013381200400_awz222-B40","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/bmj.1.6013.797","article-title":"Complement and meningococcal infection","volume":"1","author":"Greenwood","year":"1976","journal-title":"Br Med J"},{"key":"2019103013381200400_awz222-B41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/imr.12467","article-title":"More than complementing tolls: complement-toll-like receptor synergy and crosstalk in innate immunity and inflammation","volume":"274","author":"Hajishengallis","year":"2016","journal-title":"Immunol Rev"},{"key":"2019103013381200400_awz222-B42","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1182\/blood-2016-08-732800","article-title":"Incomplete inhibition by eculizumab: mechanistic evidence for residual C5 activity during strong complement activation","volume":"129","author":"Harder","year":"2017","journal-title":"Blood"},{"key":"2019103013381200400_awz222-B43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00281-017-0655-8","article-title":"Expanding horizons in complement drug discovery: challenges and emerging strategies","volume":"40","author":"Harris","year":"2018","journal-title":"Semin Immunopathol"},{"key":"2019103013381200400_awz222-B44","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.it.2012.06.001","article-title":"The complotype: dictating risk for inflammation and infection","volume":"33","author":"Harris","year":"2012","journal-title":"Trends Immunol"},{"key":"2019103013381200400_awz222-B45","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1093\/hmg\/ddm265","article-title":"Heterozygosity of mannose-binding lectin (MBL2) genotypes predicts advantage (heterosis) in relation to fatal outcome in intensive care patients","volume":"16","author":"Hellemann","year":"2007","journal-title":"Hum Mol Genet"},{"key":"2019103013381200400_awz222-B46","doi-asserted-by":"crossref","first-page":"e01755","DOI":"10.1128\/mBio.01755-17","article-title":"Complement C5a receptor 1 exacerbates the pathophysiology of N. meningitidis sepsis and is a potential target for disease treatment","volume":"9","author":"Herrmann","year":"2018","journal-title":"mBio"},{"key":"2019103013381200400_awz222-B47","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(98)08350-0","article-title":"Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease","volume":"353","author":"Hibberd","year":"1999","journal-title":"Lancet"},{"key":"2019103013381200400_awz222-B48","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"New Engl J Med"},{"key":"2019103013381200400_awz222-B49","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/jnnp.2006.110023","article-title":"Cognitive outcome in adults after bacterial meningitis","volume":"78","author":"Hoogman","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2019103013381200400_awz222-B50","doi-asserted-by":"crossref","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock","volume":"2","author":"Hotchkiss","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2019103013381200400_awz222-B51","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study","volume":"16","author":"Howard","year":"2017","journal-title":"Lancet Neurol"},{"key":"2019103013381200400_awz222-B52","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":"Effect of pneumococcal conjugate vaccine on pneumococcal meningitis","volume":"360","author":"Hsu","year":"2009","journal-title":"New Engl J Med"},{"key":"2019103013381200400_awz222-B53","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm1419","article-title":"Generation of C5a in the absence of C3: a new complement activation pathway","volume":"12","author":"Huber-Lang","year":"2006","journal-title":"Nat Med"},{"key":"2019103013381200400_awz222-B54","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/infdis\/160.4.715","article-title":"Inhibition of complement-factor-5a-induced inflammatory reactions by prostaglandin E2 in experimental meningitis","volume":"160","author":"Kadurugamuwa","year":"1989","journal-title":"J Infect Dis"},{"key":"2019103013381200400_awz222-B55","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12974-016-0770-9","article-title":"Mannose-binding lectin-associated serine protease 2 (MASP-2) contributes to poor disease outcome in humans and mice with pneumococcal meningitis","volume":"14","author":"Kasanmoentalib","year":"2017","journal-title":"J Neuroinflamm"},{"key":"2019103013381200400_awz222-B56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12974-015-0372-y","article-title":"Adjuvant treatment with dexamethasone plus anti-C5 antibodies improves outcome of experimental pneumococcal meningitis: a randomized controlled trial","volume":"12","author":"Kasanmoentalib","year":"2015","journal-title":"J Neuroinflamm"},{"key":"2019103013381200400_awz222-B57","first-page":"3861","article-title":"Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels","volume":"24","author":"Kavanagh","year":"2015","journal-title":"Hum Mol Genet"},{"key":"2019103013381200400_awz222-B58","doi-asserted-by":"crossref","first-page":"108.e9","DOI":"10.1016\/j.cmi.2018.03.039","article-title":"Adjuvant non-bacteriolytic and anti-inflammatory combination therapy in pneumococcal meningitis: an investigation in a mouse model","volume":"25","author":"Klein","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2019103013381200400_awz222-B59","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2019.04.032","article-title":"Resurgence of pneumococcal meningitis in Europe and Northern America","author":"Koelman","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2019103013381200400_awz222-B60","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4049\/jimmunol.3.3.157","article-title":"The Influence of active normal serum (complement) upon Meningococci","volume":"3","author":"Kolmer","year":"1918","journal-title":"J Immunol"},{"key":"2019103013381200400_awz222-B61","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2017-05-781450","article-title":"Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults","volume":"130","author":"Konar","year":"2017","journal-title":"Blood"},{"key":"2019103013381200400_awz222-B62","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1574-695X.1995.tb00022.x","article-title":"A study of pathogenic factors of Streptococcus pneumoniae strains causing meningitis","volume":"10","author":"Kostyukova","year":"1995","journal-title":"FEMS Immunol Med Microbiol"},{"key":"2019103013381200400_awz222-B63","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0140-6736(02)11223-2","article-title":"Mannose-binding lectin genotype as a risk factor for invasive pneumococcal infection","volume":"360","author":"Kronborg","year":"2002","journal-title":"Lancet"},{"key":"2019103013381200400_awz222-B64","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic\u2013uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"New Engl J Med"},{"key":"2019103013381200400_awz222-B65","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuron.2014.11.018","article-title":"NFkappaB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer\u2019s disease","volume":"85","author":"Lian","year":"2015","journal-title":"Neuron"},{"key":"2019103013381200400_awz222-B66","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.immuni.2007.07.011","article-title":"Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections","volume":"27","author":"Lim","year":"2007","journal-title":"Immunity"},{"key":"2019103013381200400_awz222-B67","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s00134-012-2792-9","article-title":"Delayed cerebral thrombosis in bacterial meningitis: a prospective cohort study","volume":"39","author":"Lucas","year":"2013","journal-title":"Intensiv Care Med"},{"key":"2019103013381200400_awz222-B68","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jinf.2016.04.009","article-title":"Neurological sequelae of bacterial meningitis","volume":"73","author":"Lucas","year":"2016","journal-title":"J Infect"},{"key":"2019103013381200400_awz222-B69","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1093\/cid\/ciu276","article-title":"Mannose-binding lectin gene, MBL2, polymorphisms are not associated with susceptibility to invasive pneumococcal disease in children","volume":"59","author":"Lundbo","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2019103013381200400_awz222-B70","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/path.1700120308","article-title":"Serum-therapy in cerebro-spinal fever","volume":"12","author":"M\u2019Kenzie","year":"1908","journal-title":"J Pathol Bacteriol"},{"key":"2019103013381200400_awz222-B71","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/eci.12419","article-title":"Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention","volume":"45","author":"Mastellos","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"2019103013381200400_awz222-B72","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM197301042880105","article-title":"Serum complement levels in bacteremia due to gram-negative organisms","volume":"288","author":"McCabe","year":"1973","journal-title":"New Engl J Med"},{"key":"2019103013381200400_awz222-B73","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm6627e1","article-title":"High risk for invasive meningococcal disease among patients receiving eculizumab (soliris) despite receipt of meningococcal vaccine","volume":"66","author":"McNamara","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019103013381200400_awz222-B74","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/cid\/civ378","article-title":"Variants in the mannose-binding lectin gene MBL2 do not associate with sepsis susceptibility or survival in a large European cohort","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2019103013381200400_awz222-B75","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jinf.2013.12.016","article-title":"Cerebrospinal fluid complement activation in patients with pneumococcal and meningococcal meningitis","volume":"68","author":"Mook-Kanamori","year":"2014","journal-title":"J Infect"},{"key":"2019103013381200400_awz222-B76","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.00008-11","article-title":"Pathogenesis and pathophysiology of pneumococcal meningitis","volume":"24","author":"Mook-Kanamori","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"2019103013381200400_awz222-B77","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1586\/1744666X.2015.1074039","article-title":"The role of complement in neurological and neuropsychiatric diseases","volume":"11","author":"Morgan","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"2019103013381200400_awz222-B78","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0167-5699(96)20028-F","article-title":"Expression of complement in the brain: role in health and disease","volume":"17","author":"Morgan","year":"1996","journal-title":"Immunol Today"},{"key":"2019103013381200400_awz222-B79","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrd4657","article-title":"Complement, a target for therapy in inflammatory and degenerative diseases","volume":"14","author":"Morgan","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"2019103013381200400_awz222-B80","author":"Murphy","year":"2017","journal-title":"Janeway\u2019s Immunobiology"},{"key":"2019103013381200400_awz222-B81","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"2019103013381200400_awz222-B82","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1056\/NEJMoa1311084","article-title":"Genetic variants in C5 and poor response to eculizumab","volume":"370","author":"Nishimura","year":"2014","journal-title":"New Engl J Med"},{"key":"2019103013381200400_awz222-B83","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1039\/C6CS00076B","article-title":"Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery","volume":"45","author":"Oller-Salvia","year":"2016","journal-title":"Chem Soc Rev"},{"key":"2019103013381200400_awz222-B84","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2249.2006.03140.x","article-title":"Mannose-binding lectin does not act as an acute-phase reactant in adults with community-acquired pneumococcal pneumonia","volume":"145","author":"Perez-Castellano","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"2019103013381200400_awz222-B85","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S1474-4422(13)70076-0","article-title":"Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study","volume":"12","author":"Pittock","year":"2013","journal-title":"Lancet Neurol"},{"key":"2019103013381200400_awz222-B86","doi-asserted-by":"crossref","first-page":"e015080","DOI":"10.1136\/bmjopen-2016-015080","article-title":"Bacterial meningitis in Finland, 1995\u20132014: a population-based observational study","volume":"7","author":"Polkowska","year":"2017","journal-title":"BMJ Open"},{"key":"2019103013381200400_awz222-B87","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.molimm.2017.05.013","article-title":"Complement in clinical medicine: clinical trials, case reports and therapy monitoring","volume":"89","author":"Ricklin","year":"2017","journal-title":"Mol Immunol"},{"key":"2019103013381200400_awz222-B88","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00005792-198409000-00001","article-title":"Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency","volume":"63","author":"Ross","year":"1984","journal-title":"Medicine"},{"key":"2019103013381200400_awz222-B89","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1016\/j.vaccine.2017.06.070","article-title":"Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children","volume":"35","author":"Ruiz-Contreras","year":"2017","journal-title":"Vaccine"},{"key":"2019103013381200400_awz222-B90","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.4049\/jimmunol.178.3.1861","article-title":"Complement C1q and C3 are critical for the innate immune response to Streptococcus pneumoniae in the central nervous system","volume":"178","author":"Rupprecht","year":"2007","journal-title":"J Immunol"},{"key":"2019103013381200400_awz222-B91","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/brain\/awh711","article-title":"Neuropsychological sequelae of bacterial and viral meningitis","volume":"129","author":"Schmidt","year":"2006","journal-title":"Brain"},{"key":"2019103013381200400_awz222-B92","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1212\/WNL.0b013e3181c55d2e","article-title":"Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis","volume":"73","author":"Schut","year":"2009","journal-title":"Neurology"},{"key":"2019103013381200400_awz222-B93","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1182\/blood-2010-02-269746","article-title":"Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis","volume":"116","author":"Silasi-Mansat","year":"2010","journal-title":"Blood"},{"key":"2019103013381200400_awz222-B94","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1128\/BR.21.4.273-294.1957","article-title":"Antimicrobial factors of normal tissues and fluids","volume":"21","author":"Skarnes","year":"1957","journal-title":"Bacteriol Rev"},{"key":"2019103013381200400_awz222-B95","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1046\/j.1365-2249.1999.01056.x","article-title":"Properdin deficiency in a large Swiss family: identification of a stop codon in the properdin gene, and association of meningococcal disease with lack of the IgG2 allotype marker G2m(n)","volume":"118","author":"Spath","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"2019103013381200400_awz222-B96","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1182\/blood-2003-03-0703","article-title":"Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis","volume":"102","author":"Sprong","year":"2003","journal-title":"Blood"},{"key":"2019103013381200400_awz222-B97","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0140-6736(05)63877-9","article-title":"Complement C3 and factor B cerebrospinal fluid concentrations in bacterial and aseptic meningitis","volume":"349","author":"Stahel","year":"1997","journal-title":"Lancet"},{"key":"2019103013381200400_awz222-B98","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00134-018-5270-1","article-title":"Understanding central nervous system efficacy of antimicrobials","volume":"45","author":"Tattevin","year":"2019","journal-title":"Intensiv Care Med"},{"key":"2019103013381200400_awz222-B99","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0882-4010(86)90028-8","article-title":"The role of complement in inflammation during experimental pneumococcal meningitis","volume":"1","author":"Tuomanen","year":"1986","journal-title":"Microbial Pathogenesis"},{"key":"2019103013381200400_awz222-B100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/cid\/ciy872","article-title":"Impact of 13-pneumococcal conjugate vaccine among adults: a systematic review and meta-analysis","volume":"69","author":"Vadlamudi","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2019103013381200400_awz222-B101","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(12)61808-X","article-title":"Progress and challenges in bacterial meningitis","volume":"380","author":"van de Beek","year":"2012","journal-title":"Lancet"},{"key":"2019103013381200400_awz222-B102","doi-asserted-by":"crossref","first-page":"16074","DOI":"10.1038\/nrdp.2016.74","article-title":"Community-acquired bacterial meningitis","volume":"2","author":"van de Beek","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2019103013381200400_awz222-B103","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(12)61186-6","article-title":"Advances in treatment of bacterial meningitis","volume":"380","author":"van de Beek","year":"2012","journal-title":"Lancet"},{"key":"2019103013381200400_awz222-B104","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.cmi.2016.01.007","article-title":"ESCMID guideline: diagnosis and treatment of acute bacterial meningitis","volume":"22","author":"van de Beek","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2019103013381200400_awz222-B105","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1473-3099(04)00937-5","article-title":"Steroids in adults with acute bacterial meningitis: a systematic review","volume":"4","author":"van de Beek","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"2019103013381200400_awz222-B106","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJMoa040845","article-title":"Clinical features and prognostic factors in adults with bacterial meningitis","volume":"351","author":"van de Beek","year":"2004","journal-title":"New Engl J Med"},{"key":"2019103013381200400_awz222-B107","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMra052116","article-title":"Community-acquired bacterial meningitis in adults","volume":"354","author":"van de Beek","year":"2006","journal-title":"New Engl J Med"},{"key":"2019103013381200400_awz222-B108","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/cei.12890","article-title":"Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders","volume":"187","author":"Wehling","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"2019103013381200400_awz222-B109","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"2019103013381200400_awz222-B110","doi-asserted-by":"crossref","first-page":"21057","DOI":"10.2807\/1560-7917.ES2015.20.10.21057","article-title":"Impact of 10- and 13-valent pneumococcal conjugate vaccines on incidence of invasive pneumococcal disease in children aged under 16 years in Germany, 2009 to 2012","volume":"20","author":"Weiss","year":"2015","journal-title":"Eurosurveillance"},{"key":"2019103013381200400_awz222-B111","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jcp.30.8.720","article-title":"Cerebrospinal fluid immunoglobulins and complement in meningococcal meningitis","volume":"30","author":"Whittle","year":"1977","journal-title":"J Clin Pathol"},{"key":"2019103013381200400_awz222-B112","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1172\/JCI57522","article-title":"Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis","volume":"121","author":"Woehrl","year":"2011","journal-title":"J Clin Invest"},{"key":"2019103013381200400_awz222-B113","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1128\/IAI.00291-08","article-title":"Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway","volume":"76","author":"Yuste","year":"2008","journal-title":"Infect Immun"},{"key":"2019103013381200400_awz222-B114","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/infdis\/145.2.635","article-title":"Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis","volume":"145","author":"Zwahlen","year":"1982","journal-title":"J Infect Dis"},{"key":"2019103013381200400_awz222-B115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1086\/518609","article-title":"C1 inhibitor treatment improves host defense in pneumococcal meningitis in rats and mice","volume":"196","author":"Zwijnenburg","year":"2007","journal-title":"J Infect Dis"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/142\/11\/3325\/30329815\/awz222.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/142\/11\/3325\/30329815\/awz222.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:03:24Z","timestamp":1694995404000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/142\/11\/3325\/5543074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,2]]},"references-count":115,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,8,2]]},"published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awz222","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2019,8,2]]}}}